The U.S. Food and Drug Administration (FDA) granted a full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent ...

The effect of LL-BFRT on lower extremity muscle improvement has been widely discussed ... Muscle hypertrophy including muscle cross-sectional area (CSA) or muscle thickness (MTH) was measured by MRI ...